- Home
- XENE vs KEN Comparison
XENE vs KEN Comparison
Compare XENE & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | KEN |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | Canada | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.6B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XENE | KEN |
|---|---|---|
| Price | $55.97 | $79.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $67.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 15.0K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $311,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,823.63 | N/A |
| P/E Ratio | ★ N/A | $9.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.74 | $27.10 |
| 52 Week High | $62.91 | $85.89 |
Technical Indicators
Market Signals| Indicator | XENE | KEN |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 46.63 |
| Support Level | $38.36 | $77.29 |
| Resistance Level | N/A | $85.27 |
| Average True Range (ATR) | 2.41 | 1.96 |
| MACD | 1.56 | -0.95 |
| Stochastic Oscillator | 67.32 | 9.71 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.